Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (61-70 of 175) with videos related to

Pageof 18
Sort By:
Cancer Biology & Therapy|November 13, 2004
DNA hypomethylation is prevalent even in low-grade breast cancersKesmic Jackson, Mimi C Yu, Kazuko Arakawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
DNA methylation in serum and tumors of cervical cancer patientsAndreas Widschwendter, Hannes M Müller, Heidi Fiegl, et al.
International Journal of Cancer|February 22, 2023
HPV-induced host epigenetic reprogramming is lost upon progression to high-grade cervical intraepithelial neoplasiaChiara Herzog, Charlotte D Vavourakis, James E Barrett, et al.
Cancer Research|June 3, 2004
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifenMartin Widschwendter, Kimberly D Siegmund, Hannes M Müller, et al.
Lancet (London, England)|April 20, 2004
Methylation changes in faecal DNA: a marker for colorectal cancer screening?Hannes M Müller, Michael Oberwalder, Heidi Fiegl, et al.
Gynecologic Oncology|April 22, 2004
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancerAndreas Widschwendter, Hannes M Müller, Michael M Hubalek, et al.
Cancer Research|August 17, 2002
hCDC4 gene mutations in endometrial cancerCharles H Spruck, Heimo Strohmaier, Olle Sangfelt, et al.
Communications Medicine|February 11, 2026
Short-term hormonal modulation with mifepristone does not induce oncogenic changes in the endometrium of BRCA1/2 pathogenic variant carriersMartin Widschwendter, Chiara Herzog, Mohammed Fatih Rasul, et al.
International Journal of Cancer|January 30, 2004
CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsAndreas Widschwendter, Lennart Ivarsson, Anya Blassnig, et al.
International Journal of Cancer|September 12, 2022
Assessing the risk of cervical neoplasia in the post-HPV vaccination eraMatti Lehtinen, Ville N Pimenoff, Belinda Nedjai, et al.
Pageof 18

Showing results (61-70 of 175) with videos related to

Sort By:
Pageof 18
Cancer Biology & Therapy|November 13, 2004
DNA hypomethylation is prevalent even in low-grade breast cancersKesmic Jackson, Mimi C Yu, Kazuko Arakawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
DNA methylation in serum and tumors of cervical cancer patientsAndreas Widschwendter, Hannes M Müller, Heidi Fiegl, et al.
International Journal of Cancer|February 22, 2023
HPV-induced host epigenetic reprogramming is lost upon progression to high-grade cervical intraepithelial neoplasiaChiara Herzog, Charlotte D Vavourakis, James E Barrett, et al.
Cancer Research|June 3, 2004
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifenMartin Widschwendter, Kimberly D Siegmund, Hannes M Müller, et al.
Lancet (London, England)|April 20, 2004
Methylation changes in faecal DNA: a marker for colorectal cancer screening?Hannes M Müller, Michael Oberwalder, Heidi Fiegl, et al.
Gynecologic Oncology|April 22, 2004
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancerAndreas Widschwendter, Hannes M Müller, Michael M Hubalek, et al.
Cancer Research|August 17, 2002
hCDC4 gene mutations in endometrial cancerCharles H Spruck, Heimo Strohmaier, Olle Sangfelt, et al.
Communications Medicine|February 11, 2026
Short-term hormonal modulation with mifepristone does not induce oncogenic changes in the endometrium of BRCA1/2 pathogenic variant carriersMartin Widschwendter, Chiara Herzog, Mohammed Fatih Rasul, et al.
International Journal of Cancer|January 30, 2004
CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsAndreas Widschwendter, Lennart Ivarsson, Anya Blassnig, et al.
International Journal of Cancer|September 12, 2022
Assessing the risk of cervical neoplasia in the post-HPV vaccination eraMatti Lehtinen, Ville N Pimenoff, Belinda Nedjai, et al.
Pageof 18